ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I" PATHWAY AND METHODS OF USE THEREOF
申请人:Kineta Immuno-Oncology LLC
公开号:US20200071316A1
公开(公告)日:2020-03-05
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.